Services
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Non-Human Primate (NHP) Pain Model Development Service
Are you currently facing high failure rates in clinical trials, poor translation from rodent models, and a lack of predictive biomarkers for your analgesic drug candidates? Our NHP Pain Models Model Development service helps you accelerate your drug discovery process and increase your chances of clinical success by leveraging advanced non-human primate models and cutting-edge technology. Through our advanced scientific expertise and innovative platforms, we provide a more accurate and reliable assessment of drug efficacy and safety.
Introduction of NHP Pain Models Development
What Our Service Is
Our NHP Pain Models Model Development service is a preclinical research solution that utilizes NHPs to study pain mechanisms and evaluate the efficacy of new analgesic drugs. This service is designed to overcome the limitations of traditional rodent models by providing a more translationally relevant platform. The genetic, physiological, and anatomical similarities between NHPs and humans make these models ideal for studying complex pain conditions, including neuropathic and inflammatory pain. This service is a valuable tool for:
- Preclinical Efficacy Screening: Testing and validating novel drug candidates targeting a wide range of pain indications.
- Biomarker Discovery: Identifying and validating translatable biomarkers for pain that can be used in both preclinical and clinical studies.
- Pharmacology and Safety Assessment: Evaluating the safety and pharmacological profile of new analgesics in a model that closely mimics human responses.
Why Choose Us?
The over-reliance on rodent models has led to countless failures in clinical trials, where promising compounds unexpectedly fail to show efficacy or safety. This is due to fundamental species differences in pain biology, drug metabolism, and behavioral responses. Creative Biolabs provides a solution to this pain point by offering a platform with a high degree of translational relevance. We deliver precise, reproducible data, increasing the confidence in your drug candidates and minimizing the risk of costly clinical trial failures.
Distributed under Unsplash License, from Unsplash.
Key Benefits of Our Service
At Creative Biolabs, our NHP Pain Models offer distinct advantages that position your project for success. Our platform provides a more accurate and predictive assessment of analgesic candidates, helping you make informed decisions and accelerate your pipeline.
- Speed and Efficiency: Our streamlined workflows and deep experience allow for a fast turnaround, with studies often beginning in as little as two weeks. We provide clear data and in-depth analysis to expedite your decision-making process.
- Unmatched NHP Resources: We maintain a substantial colony of well-characterized cynomolgus and rhesus macaques, ensuring immediate availability and a consistent source for your studies.
- Advanced Customization: We offer a variety of validated pain models, including Thermal Pain, Formalin-induced Pain, and Partial Sciatic Nerve Ligation (PSNL), which can be customized to align with your specific research objectives and drug target mechanisms.
- Comprehensive Data Reporting: Our reports go beyond raw data. We integrate behavioral, sensory, imaging, and neurophysiological endpoints for a robust, multi-dimensional evaluation. This includes behavioral scoring, mechanical and thermal hyperalgesia testing, and advanced analysis using technologies like AI-based 3D behavioral tracking to quantify spontaneous pain behaviors.
How Creative Biolabs' NHP Model Development Can Assist Your Project?
Our NHP Pain Models provide a clear, structured path to validating your therapeutic candidates. We ensure every step of the process is transparent and grounded in sound scientific methodology.
01
Required Starting Materials
02
Project Scoping and Design
03
Animal Conditioning and Baseline Measurement
04
Model Induction and Dosing
05
Endpoint Assessment and Data Collection
06
Data Analysis and Reporting
Key Deliverables
Clients receive a comprehensive package of deliverables upon project completion, including:
- Final Study Report with detailed methods, results, and conclusions.
- Raw and analyzed data in a client-friendly digital format.
- Model annotations and behavioral scoring sheets.
- Statistical analysis and data visualizations (graphs and charts).
Capabilities & Partnerships
Service-Specific Data
- Annual Sample Size: Over 50,000 samples analyzed per year.
- Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
- Study Pass Rate: 99%+ success rate in meeting study endpoints.
Our Valued Partners
Frequently Asked Questions
Q: How do NHP models improve upon rodent models for pain research?
A: NHP models offer a higher degree of translational relevance due to their genetic and physiological similarity to humans. Unlike rodents, NHPs can be evaluated using clinically validated tools and exhibit pain behaviors and drug responses that more accurately reflect human conditions.
Q: Are there different types of pain models available?
A: Yes. We offer a variety of established models to suit different research needs. For chronic pain, we use models like PSNL, which mimics human neuropathic pain. For acute pain, we use models like the Formalin-induced pain model. We can help you select the most appropriate model for your specific project.
Q: How can I be sure the data is reliable?
A: Our data collection and analysis are rigorous. We use state-of-the-art technologies, including AI-based behavioral analysis, to provide objective and quantitative data. Our scientific team has decades of experience in preclinical pharmacology, and we provide a comprehensive, transparent report that includes all data and statistical analysis.
Q: What if our compound is a biological or gene therapy?
A: NHPs are the gold-standard model for evaluating complex biological and gene therapies. Their immune systems and physiological pathways are more similar to humans, providing an invaluable platform for assessing the efficacy, safety, and pharmacokinetics of these next-generation therapeutics.
Contact Us
Creative Biolabs is your premier partner in advancing the field of pain research. By providing a scientifically-validated and efficient preclinical platform, we help you overcome the challenges of traditional models and accelerate your path to a successful therapeutic. Contact our team for more information and to discuss your project.